Search

Displaying results 131 - 140 of 679 in total
  1. Drug

    Protamine sulfate

    go.drugbank.com/drugs/DB09141
    ApprovedInvestigational

    Since it's earliest discovery in salmon rine sperm heads in the late 1800's to its formal introduction via US FDA approval in 1939, protamine sulfate has occupied an important therapeutic niche as perhaps the only viable option for rever...

  2. Indication

    Diabetic Ketoacidosis

    go.drugbank.com/conditions/DBCOND0000979
    Drugs: Insulin aspart · Insulin degludec · Insulin detemir · Insulin lispro · Metformin · Somatostatin
  3. Drug

    Triclosan

    go.drugbank.com/drugs/DB08604
    Approved

    An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, t...

    Products: Wild Strawberry Antibacterial Hand Wash, Anti-Bacterial Moisturizing Hand Wild Honeysuckle
  4. Indication

    Cardiovascular Risk

    go.drugbank.com/conditions/DBCOND0039927
    Drugs: Acetylsalicylic acid · Atorvastatin · Dapagliflozin · Dulaglutide · Icosapent ethyl · Metformin +1 more
  5. Indication

    High risk for progression to severe disease

    go.drugbank.com/conditions/DBCOND0143965
    Drugs: Anakinra · Dapagliflozin · Empagliflozin · Imdevimab · Metformin · Nirmatrelvir +3 more
  6. Drug

    Nisevokitug

    go.drugbank.com/drugs/DB17561
    Investigational

    Nisevokitug is a monoclonal antibody targeted against transforming growth factor beta (TGFβ) under investigation in NCT04097821 (A Randomized, Open-label, Phase I/II Open Platform Study Evaluating Safety

  7. Drug

    Rineterkib

    go.drugbank.com/drugs/DB17560
    Investigational

    Rineterkib is an inhibitor of extracellular signal-regulated kinase (ERK) being investigated in NCT04097821 (A Randomized, Open-label, Phase I/II Open Platform Study Evaluating Safety and Efficacy of Novel

  8. Drug

    Dextropropoxyphene

    go.drugbank.com/drugs/DB00647
    ApprovedIllicitWithdrawn

    Dextropropoxyphene is an opioid analgesic manufactured by Eli Lilly and Company. It is used in the symptomatic treatment of mild pain. It displays antitussive and local anaesthetic actions. Due to the risk of cardiac arrhythmias and over...

  9. Drug

    Deutivacaftor

    go.drugbank.com/drugs/DB15141
    ApprovedInvestigational

    Deutivacaftor is a small molecule cystic fibrosis transmembrane conductance regulator (CFTR) potentiator. It is used alongside CFTR correctors to increase the quantity and function of CFTR at the cell surface in patients with cystic fibr...

  10. Indication

    Polyendocrine metabolic ovarian syndrome (PMOS)

    go.drugbank.com/conditions/DBCOND0174253
    Drugs: Ethynodiol diacetate · Finasteride · Letrozole · Luteinizing hormone · Mestranol · Metformin +3 more